Metabolic reprogramming by anti-mitochondrial agent promotes the antitumor efficacy of telomerase-specific oncolytic adenoviruses against virotherapy-resistant pancreatic cancer
Metabolic reprogramming by anti-mitochondrial agent promotes the antitumor efficacy of telomerase-specific oncolytic adenoviruses against virotherapy-resistant pancreatic cancer
复制标题
抗线粒体药物的代谢重编程促进端粒酶特异性溶瘤腺病毒对病毒疗法耐药的胰腺癌的抗肿瘤功效
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Fujiwara T
中科院分区：
文献类型：
--
作者：
Shoji R;Tazawa H;Nagai Y;Yamada M;Kajiwara Y;Kikuchi S;Kuroda S;Urata Y;Kagawa S;Fujiwara T
